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Abstract
Background: The lipid content of the chylomicrons is a key biomarker and risk factor of cardiovascular diseases and for 
the understanding of obesity. A high throughput determination of chylomicrons in human blood plasma is outlined.
Methods: The new method, which uses a combination of Nuclear Magnetic Resonance (NMR) analysis and 
multivariate calibration analysis (chemometrics), is based on a correlation analysis towards the established standard 
method (ultracentrifugation and colorimetric test kit) and enables extraordinarily fast, inexpensive, and robust 
prediction of triglyceride (TG) content in chylomicrons. It is the position and shape of the complex lipid methylene 
resonance band that determines the chylomicron TG status and this information is extracted by the multivariate 
regression method.
Results: The resulting method is a relatively simple multivariate model that facilitates parsimonious and accurate 
prediction of chylomicron lipids from NMR spectra of blood. The chemometric model predicts the chylomicron TG 
content with a correlation coefficient (R) of 0.96 when plotted against density gradient ultracentrifugation data.
Conclusions: The new rapid method facilitates large scale clinical and nutritional trials with inclusion of diagnostics of 
chylomicron status and thus creates new opportunities for research in lifestyle diseases and obesity.
Background
Most of our current knowledge on the link between lip-
ids, lipoprotein metabolism and cardiovascular disease
(CVD) development relies on observations made on fast-
ing individuals. Actually, we spend the vast majority of
our time in a non-fasting postprandial state and recent
studies indicate that plasma postprandial triglyceride
(TG) concentrations are better at predicting risk of CVD
than fasting levels [1]. When fat is absorbed in the human
body, it enters the circulation in the form of intestinally
derived TG-rich lipoproteins, essentially chylomicrons,
usually within about 15 minutes after finishing a meal.
The chylomicrons are released by exocytosis in the villi of
the small intestine and are then secreted into the blood-
stream at the thoracic duct's connection with the left sub-
clavian vein. Chylomicrons are large micellar
lipoproteins, having a diameter of 75 to 1200 nm, and are
primarily composed of TG (85%) and contain some cho-
lesterol and cholesteryl esters. They are surrounded by a
surface monolayer of phospholipids, unesterified choles-
terol and specific apoproteins. Until now Low Density
Lipoprotein (LDL) cholesterol has been the primary sus-
pect in the development of coronary artery disease [2].
However, it remains unclear why 40% of people who are
h i g h l y  v u l n e r a b l e  t o  s u f f e r i n g  a  s t r o k e  o r  h e a r t  a t t a c k
have low or normal low density lipoprotein (LDL) levels.
It is possible that chylomicron adhesion on arterial walls
may be as important a risk factor as low density lipopro-
tein (LDL) cholesterol in causing strokes and heart
attacks [3]. To determine an individual's ability to clear
postprandial lipids or the capacity of a food ingredient to
diminish lipid uptake, TG-rich lipoproteins and, in par-
ticular, chylomicrons can be measured after an oral fat
load.
The "gold standard" analytical method for measuring
TG concentration in chylomicrons and lipoproteins is
fractionation by density gradient ultracentrifugation fol-
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lowed by colorimetric determination of TG (UC-TG) [4].
Unfortunately this is a time and labor-intensive method
wherefore the number of samples that can simultaneously
be analyzed is small and, as a consequence, the assess-
m e n t  o f  p o s t p r a n d i a l  l i p o p r o t e i n  m e t a b o l i s m  i s  r a r e l y
done in large clinical trials. However, as recently demon-
strated [5,6], proton NMR spectroscopy and curve-fitting
represent an alternative method for the measurement of
postprandial TG-rich lipoproteins in humans.
Proton NMR (1H-NMR) spectroscopy has recently
become an indispensable analytical technique for charac-
terization of complex biological samples such as metabo-
lite mapping in tissue and body fluids [7]. Lipoproteins
have quite similar compositions and thus their subgroups
give rise to very similar NMR signals. However , it has
been shown that NMR signals of lipoproteins in blood are
weakly shifted in frequency due to the different densities
of the lipoproteins, giving rise to different local magnetic
fields [8]. Extraction of quantitative information from
NMR spectra is classically performed by curve fitting
and/or integration of peaks [9-13]. However, in this study
it is demonstrated that a multivariate pattern recognition
approach, such as that employed for lipoprotein sub-
groups in human blood [14], can make quantization more
efficient and provide robust and precise determinations.
The mathematical basis for the fundamental advances in
high throughput metabonomics [15] has largely been due
to the use of multivariate models such as principal com-
ponent analysis (PCA) [16] and partial least squares (PLS)
regression [17], and facilitated by the ongoing computer-
ized revolution.
In this study we demonstrate how NMR spectroscopy
in combination with multivariate chemometric regres-
sion can be used to efficiently and accurately determine
TG content of chylomicrons in human plasma. The
results are regressed towards the ultracentrifugation ref-
erence method which represents the limiting step in
exploiting the full potential of the new method here pre-
sented; for example, if the ultracentrifugation method is
unable to perfectly separate the chylomicron fraction
from the very close very low density lipoprotein (VLDL)
one. To demonstrate the performance of the new method,
human blood samples were obtained after ingestion of
test meals varying in fiber content, as dietary fibers are
known to affect postprandial lipemia [18].
Methods
Study design
The presented samples are a subset of human plasma
samples which was part of a larger double-blinded ran-
domized crossover single-meal study investigating the
postprandial lipoprotein response as a function of dietary
fiber intake, in which 18 young apparently healthy normal
to moderately overweight males participated (age: 27.2 ±
4.0; BMI: 25.4 ± 2.2 kg/m2). No exclusion criteria were
applied related to lipemia, but results indicate that sub-
jects had normal to high cholesterol and TG plasma con-
centrations. Baseline blood samples (0 minutes) were
drawn after an overnight fast. Hereafter, the subjects con-
sumed one of four iso-caloric test breakfast meals (differ-
ing in dietary fiber content) within 20 minutes and
additional blood samples were drawn at 30, 60, 120, 180,
240, 300 and 420 minutes. The blood samples were col-
lected in tubes containing EthyleneDiamineTetraacetic
Acid (EDTA) and placed on ice. The samples were centri-
fuged at 2800 rpm for 15 minutes at 4°C. Plasma was
extracted and stored overnight at 4°C before NMR analy-
sis. The large study design included a total of 576 plasma
samples out of which 192 samples, equally representing
each sampling time point, were selected for the UC-TG
measurements for calibrating the PLS regression model.
The clinical part of the study was carried out at the
Department of Human Nutrition (University of Copen-
hagen) and was approved by the Municipal Ethical Com-
mittee of Copenhagen in accordance with the Helsinki
declaration (KF 01-309595). The large study is described
in more detail elsewhere (Kristensen et al., under review).
NMR spectroscopy
Samples for NMR analysis were prepared by mixing 500
μl plasma and 60 μl D2O. 1H NMR spectra were acquired
at 37°C on a Bruker Avance 500 spectrometer (Bruker
Biospin GmbH, Rheinstetten, Germany) operating at a
Larmor frequency of 500.13 MHz for 1H (11.75 Tesla) and
using a 1H/13C Z-gradient 4 mm diameter, 120 μl active
volume flow-probe. The spectra were recorded using the
zgcppr Bruker standard pulse sequence. The relaxation
delay was 5.0 s during which water presaturation was per-
formed at 4.700 ppm. The 90 degree pulses had duration
of 8.0 μs. The acquisition time for acquiring 32 k data
point free induction decays was 1.573 s using a spectral
width of 20.8278 ppm. A total of 64 scans were acquired
and each free induction decay was zero-filled to 64 k
points and apodized by a Lorentzian line-broadening of
0.3 Hz. Phase and baseline correction were performed
manually. All spectra were referenced to the anomeric
proton of -D-Glucose at 5.23 ppm. Processing was per-
formed using Bruker Topspin™ 1.3 software. Due to occa-
sional problems with the NMR flow probe, only 153
sample spectra out of the selected 192 were available for
comparison with the UC-TG data.
Ultracentrifugation
Chylomicron fractions were isolated by ultracentrifuga-
tion as described in details elsewhere [19]. In short, 3 ml
of plasma for each sample was carefully overlaid with 2.5
ml salt solution of density 1.006 Kg/L in ultracentrifuga-
tion tubes which were then centrifuged for 23 minutes atSavorani et al. Nutrition & Metabolism 2010, 7:43
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30000 rpm in an ultracentrifuge. The tubes were then
sliced 45 mm from the bottom and the TG concentration
was measured for the top-fraction, containing primarily
chylomicrons and presumably minor amounts of very low
density lipoproteins (VLDL), and for a corresponding
plasma sample (total TG) by a colorimetric test kit
(Roche TG, Roche Diagnostics GmbH, Mannheim, Ger-
many). The intra- and inter-assay precisions were 0.6%
and 1.4%, respectively. For reference purposes, total cho-
lesterol was assessed using a colorimetric test kit (Roche
TG, Roche Diagnostics GmbH, Mannheim, Germany),
intra-assay precision is 0.9%, no inter-assay precision is
provided as all samples for the same subject were ana-
lyzed in the same run. Analytical sensitivity for both TG
and total cholesterol is 0.01 mmol/L.
Multivariate data analysis
Multivariate data analysis (chemometrics) is a necessity
to study the full dimension of NMR metabonomics data
sets. Chemometrics is based on latent variables and facil-
itates an inductive exploratory strategy which is of funda-
mental scientific importance as a complement to the
ubiquitous deductive research strategies [20]. For devel-
oping the new method, PLS regression [17] was used.
This chemometric technique applies to the simultaneous
analysis of two sets of variables on the same objects and is
used in quantitative spectroscopy to correlate the spec-
troscopic data (X-block - fast multivariate measure-
ments) to a univariate physico-chemical data (y-block -
time consuming and laborious measurements). The main
purpose of the regression analysis in this study is to build
a model enabling the prediction of the reference UC-TG
characteristic (y) from a measured NMR spectrum (x). In
matrix notation the linear model y = Xb is obtained,
where b contains the regression coefficients that are
determined during the calibration step. The PLS-calcula-
tion starts with a covariance based calculation and, when
using mean centered data, the elements of the first latent
PLS-factor (calculated as X'y) will be proportional to the
covariance of the spectral intensities of X with respect to
the y vector of reference measurements. This illustrates
that the information in the X matrix will be extracted
guided, or supervised, by the information in y. PLS can be
applied to the entire NMR spectra as it has been previ-
ously done to lipoprotein subgroups in human plasma
[14] but, in order to develop a more parsimonious regres-
sion model, the interval partial least squares method
(iPLS) [21] was applied. This approach has previously
proven to be successful for the determination of choles-
terol in rodent plasma lipoprotein fractions [22]. The
method is identical to PLS but divides the spectrum into
a number of subintervals for each of which is developed a
unique PLS regression model. In this study all reported
PLS models are validated using full leave-one-sample-
out-at-a-time cross validation in order to avoid overfit-
ting and to present robust results. All PLS and iPLS mod-
els were performed in Matlab® (2007b, The Mathworks
Inc., Natick, MA, USA) using the itoolbox available at
http://www.models.life.ku.dk/source/.
Results
NMR peak assignment
A representative NMR spectrum (0.0-5.8 ppm) of human
plasma is shown in Figure 1, including peak assignment
of all the significant resonances. This region of the spec-
trum shows all the broad peaks of lipoprotein TG, from
the strong methyl and methylene resonances centered at
0.87 ppm and 1.28 ppm, respectively, to the broad olefinic
resonance at 5.30 ppm, with the characteristic overlap of
the alpha-anomeric proton doublet signal from the blood
glucose. Cholesterol methyl resonance is visible at the
right sidelobe of the methyl peak at 0.69 ppm. Besides the
lipid signals, the considered region contains information
from the blood sugars, the peptide side-chains and from
EDTA, used to prevent plasma from coagulating.
Partial Least Squares calibration
Table 1 sums up the ultracentrifugation results and shows
that the chylomicron TG content of the samples used in
this study ranges from 0.08 to 2.76 mmol/L providing a
reasonable range for calibration of the PLS regression
model.
The PLS calibration model resulting from the selected
153 samples using the entire NMR spectral information
to develop the PLS model yielded a resulting correlation
coefficient towards the UC-TG concentration, R2, of 0.90
and a root-mean-square-error-of-cross-validation
(RMSECV) of 0.174 mmol/L TG using just 3 principal
components. While this result is exceptionally encourag-
ing, an attempt to improve the model and its interpreta-
tion was made by application of iPLS regression. In this
extension to PLS the NMR spectra are divided into a
number of small regions or intervals for each of which a
local PLS regression model is calculated.
Figure 2A outlines the iPLS regression model to chylo-
micron TG: the horizontal dashed line shows the perfor-
mance of the full-spectrum regression model (R2 = 0.90
and RMSECV = 0.174 m mol/L TG using just 3 PLS com-
ponents as mentioned above) and the interval-bars show
the RMSECV performances of the spectral-interval
regression models. Evidently, two spectral regions can
further optimize the regression model: one region which
includes the vicinal methylene groups to the ester groups
of the TG and one region which includes the (poly)-
methylene protons centered at 1.28 ppm. Figure 2B shows
the 153 superimposed NMR spectra in the methylene
region colored according to the sample UC-TG values.
The figure reveals that the methylene peak shifts towardsSavorani et al. Nutrition & Metabolism 2010, 7:43
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Figure 1 Plasma 1H NMR spectrum. A representative 500 MHz 1H NMR spectrum of human blood covering the entire lipid region from 0.0 ppm to 
5.5 ppm. Inset shows a schematic view of the micellar chylomicron structure. The principal structures are indicated.
Table 1: Sample overview. 
Average
(mmol/L)
Standard
dev. (mmol/L)
Min
(mmol/L)
Max
(mmol/L)
Fasted chylomicron TG 
(n = 20)
0.41 0.22 0.10 0.92
Postprandial 
chylomicron TG (n = 133)
0.81 0.57 0.08 2.76
Plasma chylomicron TG 
(n = 153)
0.76 0.55 0.08 2.76
Plasma total cholesterol 4.43 0.80 3.30 6.43
Chylomicron TG content for the 153 plasma samples used for the PLS regression including all sampling time points. Ultracentrifugation 
results are shown for both fasted, postprandial and all samples (fasted + postprandial). The average, the standard deviation and the range of 
each subgroup are presented. Additionally, also the amount of total cholesterol is provided for the same samples. Accuracy of measurements 
is 0.01 mmol/L for the colorimetric methods.Savorani et al. Nutrition & Metabolism 2010, 7:43
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higher ppm with higher UC-TG content indicating that
no simple univariate model can provide a comparable
prediction model. The local PLS model performance for
the methylene peak, which gives the best and most parsi-
monious model for predicting the chylomicron TG con-
tent, is shown in Figure 3. Figure 3A shows the PLS
predicted and validated values of TG content plotted
against the ultracentrifugation measured ones. The
point-scatter around the ideal target line (x = y) demon-
strates high linearity throughout the TG range and an
unusual high NMR correlation to chylomicron TG.
Indeed, the obtained regression model has an R2 of 0.92
and a prediction error RMSECV of 0.156 mmol/L TG
using only 3 PLS components. This result is to be com-
pared to the standard deviation of 0.55 mmol/L TG
obtained on the UC-TG reference method and indicate
that the iPLS model provides a near perfect correlation to
the UC-TG data. Additional information can be derived
by inspection of the PLS regression coefficients. Figure
3B shows a superimposition of an average plasma NMR
spectrum and the corresponding PLS (#1) regression
coefficients for the main lipid spectral region (1.5-0.8
ppm). This comparison reveals that it is mainly the left
part of both the methylene and the methyl peaks which is
relevant for chylomicron TG determination, in agree-
ment with observations made from Figure 2B.
Time course study
In order to demonstrate how the presented method can
be used to monitor changes in plasma chylomicron TG
concentration as a function of time elapsed since intake
of a standardized meal, a simple time course study was
carried out for five individuals. In Figure 4A the results
obtained by the new method are shown for 8 time points
from 0 to 7 seven hours after intake of the meal. For refer-
ence, also the UC-TG results for the same time courses
are shown in Figure 4B. According to the analysis shown
above, the differences between the ultracentrifugation
and the NMR methods are at least partially due to the
much higher uncertainty of the ultracentrifugation
method. Nevertheless, the figure demonstrates the valid-
ity of the new method in monitoring postprandial TG
concentration time changes occurring for different sub-
jects.
Figure 2 iPLS statistical model. Overview of the interval PLS regression model (A). The complex distributed methylene resonance is selected and 
provides a performance superior to the overall calibration obtained using the full NMR spectrum. Inset B shows the methylene peak colored according 
to the sample content of chylomicron TG. Higher concentrations are slightly shifted towards higher chemical shift values (ppm).
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Discussion
The new method for determination of chylomicron TG
concentration offers a low sample volume, high through-
put and less expensive method that can allow extensive
measurements in large clinical metabonomics trials and
in future individual diagnostics. The time that elapses
from when the blood is sampled to when the result is pro-
duced is reduced from several hours (ultracentrifugation)
to minutes with the new method (NMR). The results
achieved are consistent with previous NMR based meth-
ods [5,6,8] even though the new method avoids the use of
curve fitting and peak integration steps, keeping the anal-
ysis simple and robust.
The iPLS approach, which for the first time is applied to
the determination of chylomicron TG, results in a simple
model which focuses on the most informative region of
the spectrum and will thus be less sensitive to variations
occurring on the overall metabolic profile.
The presented method can, with some additional cali-
bration efforts, be used for robust and automatic predic-
tion of the chylomicron TG plasma content as a routine
analysis in hospitals and as a research tool for studying
large scale clinical investigations and detailed postpran-
dial time trials.
When considering potential interferences for the new
NMR-based method, it should be emphasized that the
method is sensitive to methylene groups and their envi-
ronment. This mean all long chain fatty acids present in
the chylomicrons, independently if they are part of phos-
pholipids or diglycerides etc. Nevertheless, the spectral
features of cholesteryl esters and other rare fats in the
chylomicrons, that potentially can contribute to the
methylene resonances, are quantitatively outnumbered in
the supervised analysis and the high correlation to UC-
TG is the proof. The method's sensitivity to TGs in chylo-
microns is due to the slow diffusion of the large chylomi-
cron particles which affects the shape and position of the
methylene resonance. This NMR information can be
used to calculate the diameter of the chylomicron parti-
cles as done by Dyrby et al. [23], but in this supervised
study this information is implicitly used.
Since UC-TG is used as response in the regression anal-
ysis, and since this method does not allow a perfect sepa-
ration between chylomicrons and very low density
lipoproteins (VLDL), the new method, which performs
correlation analysis, will per definition also be affected by
the presence of this last class of lipoproteins when assess-
ing the chylomicron TG content. If the inclusion of minor
fractions of very low density lipoproteins (VLDL) in the
correlation analysis is a problem, it should result in fasted
plasma samples with a significant content of chylomicron
TG. However, this is clearly not the case as the fasted
plasma samples are all well predicted by the new method
and do not compromise the linearity of the relationship
between NMR spectral features and TG content. Albeit
the concentration of chylomicron TG in the fasted state
should theoretically be 0 mmol/L, it is well known that
some individuals do not clear lipids at the same high rate,
and that chylomicrons may be present even after an over-
night fast [19]. Furthermore, a few subjects had both high
fasting total TG (~2 mmol/L) (data not shown) and chy-
lomicron TG (~0.9 mmol/L) indicating poor lipid clear-
ance capacity, resulting in a relatively high mean fasting
chylomicron TG concentration.
Finally, the time course study conducted on five sub-
jects demonstrated good potential of the new method for
Figure 3 PLS regression performance. Cross-validated PLS regression model performance as viewed by a predicted (NMR-TG) versus measured 
(UC-TG) plot for the 153 plasma samples (A). This 3-component model is based on the spectral region 1.05-1.4 ppm and gives a correlation, R2, of 0.92 
and a RMSECV of 0.156 mmol/L. The equation of the obtained linear regression is y = 0.9955x + 0.0035 mmol/L. The main lipid spectral region and its 
PLS regression coefficients are plotted superimposed (B) showing that only the left part of both the methylene and methyl peaks are informative for 
Chylomicron TG determination.
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monitoring variations in chylomicron TG concentration
over time which is comparable or better to what can be
obtained using the ultracentrifugation method. Most
importantly, the low sample volume requirements and
high throughput capacity of the new method will allow
much more frequent time sampling for studying early
events and finer details in the time courses for postpran-
dial triglyceride (TG) concentrations after intake of stan-
dardized meals.
Due to the escalating obesity epidemic and its cardio-
metabolic complications, in combination with the estab-
lished relationship between postprandial elevation of lip-
ids and CVD risk, the search for food ingredients and
drugs that effectively suppress postprandial lipemia has
increased in recent years. To determine an individual's
ability to clear postprandial lipids or the capacity of a
food ingredient to diminish lipid uptake, TG-rich lipo-
Figure 4 Time course study. Chylomicron TG concentration level for 5 subjects as a function of time after intake of a standardized meal. (A) The PLS 
predicted values are plotted against 8 time points spanning 7 hours. (B) The reference TG results by the ultracentrifugation method. The highest con-
centration is reached between 120 and 240 min after meal.
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proteins and, in particular , chylomicrons must be mea-
sured after an oral fat load.
Conclusions
The new method facilitates rapid measurement of chylo-
micron TG and creates new opportunities for research in
lifestyle diseases and obesity and may become a valuable
tool in nutritional research for assessment of absorption
of exogenous diet-derived lipids. Furthermore, non-fast-
ing concentration of TG in TG-rich lipoproteins includ-
ing chylomicrons may replace fasting levels in assessing
CVD risk once standard reference values have been
developed, and thus a high throughput NMR method
may become a valuable tool in prediction of disease risk.
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